|
Clinical Studies
Citations 311-320 of 355 total displayed.
|
Past content
(since Nov 2000):
|
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
- David L. DeMets and Robert M. Califf
Circulation 2002;106:880-886, doi:10.1161/01.CIR.0000023220.26465.89
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part I
- David L. DeMets and Robert M. Califf
Circulation 2002;106:746-751, doi:10.1161/01.CIR.0000023219.51483.66
[Full text]
- Clinical Investigations and Reports
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment: The Losartan Intervention for Endpoint (LIFE) Study
- Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation 2002;106:227-232; published online before print as doi:10.1161/01.CIR.0000021601.49664.2A
[Abstract]
[Full text]
- Clinical Investigations and Reports
Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist System
- O. H. Frazier, Timothy J. Myers, Igor D. Gregoric, Tehreen Khan, Reynolds Delgado, Mihai Croitoru, Kathy Miller, Robert Jarvik, and Stephen Westaby
Circulation 2002;105:2855-2860; published online before print as doi:10.1161/01.CIR.0000018167.47314.AF
[Abstract]
[Full text]
- Articles
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment. The Losartan Intervention for Endpoint (LIFE) Study
- Kristian Wachtell, Vittorio Palmieri, Michael H. Olsen, Eva Gerdts, Vasilios Papademetriou, Markku S. Nieminen, Gunnar Smith, Björn Dahlöf, Gerard P. Aurigemma, and Richard B. Devereux
Circulation published June 17, 2002, doi:10.1161/01.CIR.0000021601.49664.2A
[Abstract]
- Articles
Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist System
- O. H. Frazier, Timothy J. Myers, Igor D. Gregoric, Tehreen Khan, Reynolds Delgado, Mihai Croitoru, Kathy Miller, Robert Jarvik, and Stephen Westaby
Circulation published May 28, 2002, doi:10.1161/01.CIR.0000018167.47314.AF
[Abstract]
- Clinician Update
Evaluation and Treatment of Patients With Systemic Hypertension
- Jay Garg, Adrian W. Messerli, and George L. Bakris
Circulation 2002;105:2458-2461, doi:10.1161/01.CIR.0000017143.59204.AA
[Full text]
- Clinical Investigations and Reports
Paradoxical Pressor Effects of ß-Blockers in Standing Elderly Patients With Mild Hypertension: A Beneficial Side Effect
- T.J. Cleophas, I. Grabowsky, M.G. Niemeyer, W.M. Mäkel, E.E. van der Wall on Behalf of the Nebivolol Follow-Up Study Group
Circulation 2002;105:1669-1671; published online before print as doi:10.1161/01.CIR.0000012745.50229.AC
[Abstract]
[Full text]
- AHA Scientific Statements
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients  75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention
- Mark A. Williams, Jerome L. Fleg, Philip A. Ades, Bernard R. Chaitman, Nancy Houston Miller, Syed M. Mohiuddin, Ira S. Ockene, C. Barr Taylor, and Nanette K. Wenger
Circulation 2002;105:1735-1743, doi:10.1161/01.CIR.0000013074.73995.6C
[Full text]
- Clinical Investigations and Reports
Baroreflex Buffering and Susceptibility to Vasoactive Drugs
- Jens Jordan, Jens Tank, John R. Shannon, Andre Diedrich, Axel Lipp, Christoph Schröder, Guy Arnold, Arya M. Sharma, Italo Biaggioni, David Robertson, and Friedrich C. Luft
Circulation 2002;105:1459-1464; published online before print as doi:10.1161/01.CIR.0000012126.56352.FD
[Abstract]
[Full text]
|
|
